{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:34:03Z","timestamp":1763436843969,"version":"build-2065373602"},"reference-count":62,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer worldwide. More than 90% of cases occur in cirrhotic patients, with the degree of fibrosis being the main risk factor for the development of HCC. Liver biopsy is the gold-standard for fibrosis assessment, but it is an invasive procedure. Liver stiffness measurement (LSM) has shown high accuracy for diagnosing liver cirrhosis, as well as for predicting decompensation and HCC development. More recently, spleen stiffness measurement (SSM) has presented excellent results for ruling in\/out high-risk varices and the presence of clinical significant portal hypertension. The aim of our study was to evaluate the relationship between LSM and SSM and the risk of hepatocellular carcinoma. Methods: A prospective study on cirrhotic patients was performed in a tertiary center from January 2020 to May 2024. All patients were submitted to liver and spleen elastography (with a new probe of 100 Hz) by the same blinded operator and were treated in the same institution for the development of hepatocellular carcinoma. Results: We included 299 cirrhotic patients, 75.9% male, with a mean age of 61.8 years (\u00b110.0). The median value of LSM was 25.7 kPa [4.5\u201375.0] and that of SSM was 44.6 kPa [7.9\u2013100.0]. The median follow-up time was 505 days [114.0\u20131541.0]. During this period, 18 patients developed HCC, with a median time to HCC diagnosis after LSM and SSM of 321 days [63.0\u20131227.0]. LSM was the only factor associated with the development of HCC (p = 0.002) with an AUC of 0.715. On the other hand, SSM was not associated with the development of HCC. Conclusions: We found that the risk of developing HCC is associated with liver fibrosis but not with portal hypertension (assessed using SSM).<\/jats:p>","DOI":"10.3390\/diagnostics14242867","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T06:44:33Z","timestamp":1734677073000},"page":"2867","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Liver Stiffness Measurement and Spleen Stiffness Measurement in Predicting the Risk of Developing HCC"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-3844","authenticated-orcid":false,"given":"Rui","family":"Gaspar","sequence":"first","affiliation":[{"name":"Gastroenterology and Hepatology, Centro Hospitalar de S\u00e3o Jo\u00e3o, 4200 Porto, Portugal"}]},{"given":"Joana","family":"Mota","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Centro Hospitalar de S\u00e3o Jo\u00e3o, 4200 Porto, Portugal"}]},{"given":"Maria Jo\u00e3o","family":"Almeida","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Centro Hospitalar de S\u00e3o Jo\u00e3o, 4200 Porto, Portugal"}]},{"given":"Marco","family":"Silva","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Centro Hospitalar de S\u00e3o Jo\u00e3o, 4200 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-9872","authenticated-orcid":false,"given":"Guilherme","family":"Macedo","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Centro Hospitalar de S\u00e3o Jo\u00e3o, 4200 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cgh.2007.02.039","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis","volume":"5","author":"Ioannou","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, Galle, P.R., Forner, A., Llovet, J.M., Mazzaferro, V., Piscaglia, F., Raoul, J.L., Schirmacher, P., and Vilgrain, V. (2018). EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol., 69, 182\u2013236.","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/gutjnl-2023-331695","article-title":"British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults","volume":"73","author":"Suddle","year":"2024","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vitale, A., Farinati, F., Finotti, M., Di Renzo, C., Brancaccio, G., Piscaglia, F., Cabibbo, G., Caturelli, E., Missale, G., and Marra, F. (2021). Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications. Cancers, 13.","DOI":"10.3390\/cancers13071673"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s10620-016-4085-6","article-title":"Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD","volume":"61","author":"Reeves","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyp280","article-title":"Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer","volume":"38","author":"Lee","year":"2009","journal-title":"Int. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy","volume":"131","author":"Yoshida","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1586\/17474124.2014.898563","article-title":"Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease","volume":"8","author":"Park","year":"2014","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/hep.21420","article-title":"Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases","volume":"44","author":"Ziol","year":"2006","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3280657","DOI":"10.1155\/2019\/3280657","article-title":"Emerging Trends and New Developments in Transient Elastography: A Bibliometric and Cocitation Analysis from 1999 to 2017","volume":"2019","author":"Gu","year":"2019","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: A new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014Renewing consensus in portal hypertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","article-title":"Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: A systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2022.10.030","article-title":"Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis","volume":"78","author":"Zhang","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/jgh.16344","article-title":"Spleen stiffness: A new tool to predict high-risk varices in cirrhotic patients","volume":"38","author":"Gaspar","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100289","DOI":"10.1016\/j.jhepr.2021.100289","article-title":"Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness","volume":"3","author":"Dajti","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/liv.14977","article-title":"Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses","volume":"41","author":"Allaire","year":"2021","journal-title":"Liver Int."},{"key":"ref_21","first-page":"21","article-title":"[Baveno VII\u2014Renewing consensus in portal hypertension: Personalized care for portal hypertension]","volume":"30","author":"Li","year":"2022","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref_22","first-page":"1009","article-title":"Splenomegaly as Risk Factor of Liver Cirrhosis. A Retrospective Cohort Study of 2525 Patients who Underwent Laparoscopy*","volume":"25","author":"Orlando","year":"2011","journal-title":"In Vivo"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/j.gastro.2023.06.027","article-title":"Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study","volume":"165","author":"Reddy","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.7150\/ijms.95861","article-title":"Risk Factors and Nomogram Model for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients with Low-Level Viremia","volume":"21","author":"Chen","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40644-023-00558-7","article-title":"Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: Prognostic relevance of CT-morphologic estimates","volume":"23","author":"Muller","year":"2023","journal-title":"Cancer Imaging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2022.11.019","article-title":"Treatment of portal hypertension in patients with HCC in the era of Baveno VII","volume":"78","author":"Thabut","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ueg2.12188","article-title":"Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"10","author":"Muller","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"He, X., Zhao, Z., Jiang, X., and Sun, Y. (2023). Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: A meta-analysis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1216059"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cheng, H.Y., Lin, H.C., Lin, H.L., Uang, Y.S., Keller, J.J., and Wang, L.H. (2021). Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Without Cirrhosis and Decompensation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.805318"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.14218\/JCTH.2019.00007","article-title":"TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis","volume":"7","author":"Chen","year":"2019","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"European Association for the Study of The Liver (2015). EASL Clinical Practice Guidelines: Autoimmune hepatitis. J. Hepatol., 63, 971\u20131004.","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, Hirschfield, G.M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., and Schramm, C. (2017). EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol., 67, 145\u2013172.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"European Association for the Study of The Liver (2012). EASL Clinical Practice Guidelines: Wilson\u2019s disease. J. Hepatol., 56, 671\u2013685.","DOI":"10.1016\/j.jhep.2011.11.007"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"European Association For The Study of The Liver (2010). EASL clinical practice guidelines for HFE hemochromatosis. J. Hepatol., 53, 3\u201322.","DOI":"10.1016\/j.jhep.2010.03.001"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16051","DOI":"10.1038\/nrdp.2016.51","article-title":"alpha1-Antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jhep.2008.08.018","article-title":"Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores","volume":"50","author":"Castera","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s12072-010-9223-1","article-title":"Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis","volume":"4","author":"Kuo","year":"2010","journal-title":"Hepatol. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: A meta-analysis","volume":"134","author":"Ong","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100557","DOI":"10.1016\/j.jhepr.2022.100557","article-title":"The ALBI score: From liver function in patients with HCC to a general measure of liver function","volume":"4","author":"Toyoda","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/liv.13489","article-title":"Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia","volume":"38","author":"Paik","year":"2018","journal-title":"Liver Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/jir.2019.0049","article-title":"Aspartate Aminotransferase-to-Platelet Ratio or Fibros-4 Index Predicts the Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Sustained Virologic Response to Interferon Therapy","volume":"39","author":"Na","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Peleg, N., Sneh Arbib, O., Issachar, A., Cohen-Naftaly, M., Braun, M., and Shlomai, A. (2018). Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202393"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.3748\/wjg.v26.i24.3326","article-title":"Non-invasive tests for the prediction of primary hepatocellular carcinoma","volume":"26","author":"Marasco","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1007\/s10620-019-05604-8","article-title":"Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience","volume":"64","author":"Rinaldi","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/00365521.2014.964758","article-title":"Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications","volume":"50","author":"Kitson","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The \u201cAnticipate\u201d study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MCG.0b013e31825079f1","article-title":"The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B","volume":"46","author":"Chon","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cgh.2018.10.038","article-title":"Factors Associated with Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients with Cirrhosis Treated with Direct-Acting Antivirals for HCV Infection","volume":"17","author":"Degasperi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Fung, J., Poon, R.T., Yu, W.C., Chan, S.C., Chan, A.C., Chok, K.S., Cheung, T.T., Seto, W.K., Lo, C.M., and Lai, C.L. (2013). Use of liver stiffness measurement for liver resection surgery: Correlation with indocyanine green clearance testing and post-operative outcome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072306"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/kjm2.12114","article-title":"Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agent","volume":"35","author":"Wang","year":"2019","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/cit768","article-title":"Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: Comparison of hepatic venous pressure gradient and transient elastography","volume":"58","author":"Rincon","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Moon, H., Cho, K., Shin, S., Kim, D.Y., Han, K.H., and Ro, S.W. (2019). High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP\/TAZ Signaling Pathway. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030581"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ultrasmedbio.2020.09.004","article-title":"Spleen and Liver Stiffness for Predicting High-Risk Varices in Patients with Compensated Liver Cirrhosis","volume":"47","author":"Fofiu","year":"2021","journal-title":"Ultrasound Med. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/liv.14228","article-title":"A novel spleen-dedicated stiffness measurement by FibroScan(R) improves the screening of high-risk oesophageal varices","volume":"40","author":"Stefanescu","year":"2020","journal-title":"Liver Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2468-1253(23)00150-4","article-title":"Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: A systematic review and individual patient data meta-analysis","volume":"8","author":"Dajti","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0168-8278(00)80007-0","article-title":"Hepatic microvascular features in experimental cirrhosis: A structural and morphometrical study in CCl4-treated rats","volume":"33","author":"Onori","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jhep.2018.10.022","article-title":"Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection","volume":"70","author":"Marasco","year":"2019","journal-title":"J. Hepatol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/24\/2867\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:56:18Z","timestamp":1760115378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/24\/2867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":62,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["diagnostics14242867"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14242867","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}